PACS2 and atherosclerosis: As a platform to modify the phenotypic transformation of VSMCs and ECs, p66Shc and PACS-2 located on ERMCs participates in the pathological process of atherosclerosis by modifying the mitochondrial Ca2+ overload and apoptosis, which contributes to the survival of VSMCs and ECs.